Literature DB >> 27854198

Investigation of the cytotoxicity, antioxidative and immune-modulatory effects of Ligusticum porteri (Osha) root extract on human peripheral blood lymphocytes.

Khanh Nguyen1, Jean Sparks1, Felix O Omoruyi1.   

Abstract

OBJECTIVE: Ligusticum porteri is a traditional Native American herb. The roots of L. porteri are traditionally used in the treatment of many diseases, however, its cytotoxicity, antioxidative and immune-modulatory effects need to be investigated. In this study, we evaluated the effects of the root extract at different doses on human peripheral blood lymphocytes (PBLs).
METHODS: The lymphocytes were incubated with different concentrations of the root extracts (0, 50, 100, 200, and 400 μg/mL) and harvested every 6 h for 2 d (P<0.05). The protective effect of the herb against oxidative damage was determined by inducing oxidative stress with the administration of 50 μmol/L of hydrogen peroxide (H2O2).
RESULTS: Treatments with L. porteri at 200 and 400 μg/mL increased the viability of PBLs. The deleterious effect of H2O2 was ameliorated by 400 μg/mL L. porteri treatment. Addition of 400 μg/mL L. porteri reduced lipid peroxidation in stressed PBLs by 94% (P<0.05). Treatment with 400 μg/mL of L. porteri resulted in a 26.4% increase of reduced glutathione levels. Activities of superoxide dismutase and catalase increased by 17.5% and 55.2% respectively, when stressed PBLs were treated with 400 μg/mL L. porteri for 2 d (P<0.05). Treatment with 400 μg/mL L. porteri increased interferon-γ and interleukin-2 expressions in H2O2-challenged PBLs (P<0.05), however, the root extract did not cause a significant difference in interleukin-10 levels compared to the control (P>0.05).
CONCLUSION: The findings suggest that L. porteri might be a potential immune-modulating agent involving protective effects against oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27854198     DOI: 10.1016/S2095-4964(16)60280-7

Source DB:  PubMed          Journal:  J Integr Med


  6 in total

1.  Effects of Ligusticum porteri (Osha) Root Extract on Human Promyelocytic Leukemia Cells.

Authors:  Khanh Nguyen; Jean Sparks; Felix Omoruyi
Journal:  Pharmacognosy Res       Date:  2017 Apr-Jun

2.  Insulin promotes progression of colon cancer by upregulation of ACAT1.

Authors:  Xin Chen; Huiling Liang; Qibin Song; Ximing Xu; Dedong Cao
Journal:  Lipids Health Dis       Date:  2018-05-24       Impact factor: 3.876

3.  Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells.

Authors:  Zhijing Zhao; Junfeng Ma; Ying Mao; Liying Dong; Siqi Li; Yi Zhang
Journal:  Med Sci Monit       Date:  2018-09-27

4.  A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review.

Authors:  Melissa S Barber; Richard Barrett; Ryan D Bradley; Erin Walker
Journal:  Complement Ther Med       Date:  2021-11-06       Impact factor: 2.446

5.  Bu‑Shen‑Ning‑Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4+ T lymphocytes of ovariectomized mice.

Authors:  Jia-Li Zhang; Xue-Min Qiu; Na Zhang; Wei Tang; Hans-Jürgen Gober; Da-Jin Li; Ling Wang
Journal:  Int J Mol Med       Date:  2018-04-26       Impact factor: 4.101

6.  Long noncoding RNA KCNQ1OT1 promotes proliferation and epithelial‑mesenchymal transition by regulation of SMAD4 expression in lens epithelial cells.

Authors:  Bin Chen; Jian Ma; Chunwei Li; Yong Wang
Journal:  Mol Med Rep       Date:  2018-05-08       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.